Recognition as second most innovative smaller company across all industries highlights transformative impact on public health, impactful industry collaborations, and a novel manufacturing approach ...
YOKOHAMA, Japan--(BUSINESS WIRE)--CoreTissue BioEngineering Inc. (“CTBE”), a medical device start-up developing an artificial ligament derived from decellularized animal tissue, is the first company ...
SAN FRANCISCO--(BUSINESS WIRE)--Ossium Health, a clinical-stage bioengineering company with a first-of-its-kind bone marrow banking platform for processing and deploying hematopoietic stem cells and ...
Artificial intelligence is transforming biomedical science, accelerating research and revealing new tools for drug discovery and treatments for stubborn diseases. The University of Texas at Dallas has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results